Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

SynapTau

Financiado

Targeting the interrelation between microglia, neurons, and astrocytes to counte...

Targeting the interrelation between microglia, neurons, and astrocytes to counteract tau-mediated synaptic impairments and neurodegeneration in AD. The overall aim of SynapTau is to evaluate the contribution of microglia on tau-mediated synaptic loss in Alzheimer’s disease (AD), based on synaptosomal changes, which may help to develop therapeutic strategies against AD. Determ... ver más

31/08/2024

AMU

196K€

Presupuesto del proyecto: 196K€

Líder del proyecto

UNIVERSITE DAIX MARSEILLE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-08-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2021-PF-01-01: MSCA Postdoctoral Fellowships 2021

I+D

Cerrada hace 3 años

0% 100%

1 Participantes

AMU

195.91K€ | Lider

Proyectos interesantes

PID2021-125785OA-I00 PAPEL DE LA MICROGLIA EN LA DISFUNCION SINAPTICA Y NEURONAL... 200K€ Cerrado

PID2021-125986OB-I00 IMPLICACION DE LA GLIA EN TAUPATIA: NUEVAS DIANAS TERAPEUTIC... 175K€ Cerrado

SAF2016-80236-R RELEVANCIA DEL ANTAGONISTA DE RECEPTORES DE MUERTE, FAIM-L,... 273K€ Cerrado

RTI2018-095812-B-I00 ORGANIZACION MOLECULAR DE RECEPTORES Y CANALES IONICOS ASOCI... 157K€ Cerrado

SAF2013-43902-R EL PAPEL DE LA INTERACCION PTEN-PDZ EN EL DETERIORO COGNITIV... 206K€ Cerrado

SAF2013-47989-R NEUROINFLAMACION, TNF Y ANTAGONISTAS DE LOS RECEPTORES DE MU... 290K€ Cerrado

Últimas noticias

30-11-2024: Cataluña Gestión For... Se ha cerrado la línea de ayuda pública: Gestión Forestal Sostenible para Inversiones Forestales Productivas para el organismo:

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

Duración del proyecto: 25 meses Fecha Inicio: 2022-07-06
Fecha Fin: 2024-08-31

Líder del proyecto

UNIVERSITE DAIX MARSEILLE

TRL 4-5

Presupuesto del proyecto 196K€

Descripción del proyecto The overall aim of SynapTau is to evaluate the contribution of microglia on tau-mediated synaptic loss in Alzheimer’s disease (AD), based on synaptosomal changes, which may help to develop therapeutic strategies against AD. Determining the impact of tau accumulation on synaptic loss is critical since it correlates with cognitive decline in AD. Beyond tau and amyloid-β pathologies, gliosis is also an AD hallmark and is thought to play a pivotal role on synaptic loss. Despite the link between tau, synapses and inflammation in AD, we do not yet understand the specific interactions between synaptic proteins, glia and pathological tau that lead to synaptic loss. My objective is to provide a better understanding of the role of microglia in tau-mediated synaptic loss based on recent observations I made. I recently explored synaptosomes containing glial processes near synapses from microglia depleted P301S mice, a mouse model of tauopathy, to identify changes resulting from microglia depletion that account for synaptic protection against tau pathology. I reported an upregulation of UCH-L1, an enzyme required for normal synaptic function. Moreover, most of the upregulated proteins in the synaptosomes of microglia depleted-P301S mice are expressed by astrocytes. I propose to study potential protective mechanisms against tau-mediated synaptotoxicity set in motion by microglial depletion that target neurons and neuron/astrocyte interactions. In objective 1, I hypothesize that enhancing UCH-L1 expression in neurons will protect against tau-mediated synaptic damages. In objective 2, I hypothesize that neuron-glia interactions are modified after microglia depletion, with changes in the formation and function of perisynaptic astrocytic processes that may support beneficial pathological outcomes. SynapTau is a highly significant project as it aims to discover new therapeutic targets to maintain synaptic integrity and function to slow down AD neurodegeneration and cognitive decline.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores